118 related articles for article (PubMed ID: 7683062)
1. Multiple myeloma. New approaches to therapy.
Dunbar CE; Nienhuis AW
JAMA; 1993 May; 269(18):2412-6. PubMed ID: 7683062
[No Abstract] [Full Text] [Related]
2. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.
Awedan AA
Ann Transplant; 2002; 7(2):38-43. PubMed ID: 12416471
[TBL] [Abstract][Full Text] [Related]
3. Intensive combined therapy for previously untreated aggressive myeloma.
Attal M; Huguet F; Schlaifer D; Payen C; Laroche M; Fournie B; Mazieres B; Pris J; Laurent G
Blood; 1992 Mar; 79(5):1130-6. PubMed ID: 1536941
[TBL] [Abstract][Full Text] [Related]
4. Newer approaches to the therapy of multiple myeloma.
Kyle RA
Blood; 1990 Nov; 76(9):1678-9. PubMed ID: 1699619
[No Abstract] [Full Text] [Related]
5. Kaposi's sarcoma after autologous bone marrow transplantation for multiple myeloma.
Vivancos P; Sarrá J; Palou J; Valls A; Garćia J; Grañena A
Bone Marrow Transplant; 1996 Apr; 17(4):669-71. PubMed ID: 8722373
[TBL] [Abstract][Full Text] [Related]
6. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
Alegre A; Díaz-Mediavilla J; San-Miguel J; Martínez R; García Laraña J; Sureda A; Lahuerta JJ; Morales D; Bladé J; Caballero D; De la Rubia J; Escudero A; Díez-Martín JL; Hernández-Navarro F; Rifón J; Odriozola J; Brunet S; De la Serna J; Besalduch J; Vidal MJ; Solano C; Leon A; Sánchez JJ; Martínez-Chamorro C; Fernández-Rañada JM
Bone Marrow Transplant; 1998 Jan; 21(2):133-40. PubMed ID: 9489629
[TBL] [Abstract][Full Text] [Related]
7. T-cell depleted bone marrow transplantation for plasma cell myeloma. Report of a case and review of the results of BMT for myeloma.
Yehuda AB; Or R; Naparstek E; Slavin S; Polliack A
Blut; 1988 May; 56(5):229-31. PubMed ID: 3285913
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of refractory multiple myeloma. II. Therapy using high doses of alkylating cytostatic agents and radiotherapy in addition to interferon and bone marrow transplantation].
Adam Z
Vnitr Lek; 1993 Apr; 39(4):385-400. PubMed ID: 8351869
[TBL] [Abstract][Full Text] [Related]
9. [Treatments of multiple myeloma in 1992].
Monconduit M
Rev Med Interne; 1992; 13(4):315-8. PubMed ID: 1363152
[TBL] [Abstract][Full Text] [Related]
10. Pustular eruption at the site of subcutaneous injection of recombinant human granulocyte-macrophage colony-stimulating factor.
Passweg J; Buser U; Tichelli A; Gratwohl A; Speck B
Ann Hematol; 1991 Dec; 63(6):326-7. PubMed ID: 1836742
[No Abstract] [Full Text] [Related]
11. Transplantation in multiple myeloma.
Topolsky D; Biggs D
Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
[No Abstract] [Full Text] [Related]
12. Factors influencing platelet recovery after blood cell transplantation in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Pineda AA; Chen MG; Gastineau DA; Tefferi A; Kyle RA; Litzow MR
Bone Marrow Transplant; 1997 Sep; 20(5):375-80. PubMed ID: 9339752
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemoradiotherapy with syngeneic bone marrow transplantation for multiple myeloma: a case report and literature review.
Wolff SN; McCurley TL; Giannone L
Am J Hematol; 1987 Oct; 26(2):191-8. PubMed ID: 3310614
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy in multiple myeloma.
Goldschmidt H; Hegenbart U; Wallmeier M; Moos M; Haas R
Leukemia; 1997 Dec; 11 Suppl 5():S27-31. PubMed ID: 9436935
[TBL] [Abstract][Full Text] [Related]
15. Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer.
Dunbar CE; Nienhuis AW; Stewart FM; Quesenberry P; O'Shaughnessy J; Cowan K; Cottler-Fox M; Leitman S; Goodman S; Sorrentino BP
Hum Gene Ther; 1993 Apr; 4(2):205-22. PubMed ID: 8098622
[No Abstract] [Full Text] [Related]
16. Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma.
Devine SM; Jahagirdar B; van Besien K
Blood; 2002 Jun; 99(11):4251-2; author reply 4252. PubMed ID: 12043699
[No Abstract] [Full Text] [Related]
17. Autologous blood stem cell transplantation (ABSCT) in high-risk myeloma (MM).
Marit G; Boiron JM; Pico JL; Foures C; Rice A; Cony-Makhoul P; Bernard P; Broustet A; Reiffers J
Bone Marrow Transplant; 1991; 7 Suppl 2():29. PubMed ID: 1678977
[No Abstract] [Full Text] [Related]
18. [Multiple myeloma in 1990].
Le Loët X; Monconduit M; Euller-Ziegler L
Ann Med Interne (Paris); 1990; 141(2):108-10. PubMed ID: 2191611
[No Abstract] [Full Text] [Related]
19. Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue.
Rhodes EG; Baker PK; Rhodes JM; Davies JM; Duguid JK
Bone Marrow Transplant; 1994 Jun; 13(6):795-9. PubMed ID: 7522727
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma.
Stewart AK; Dubé ID; Kamel-Reid S; Keating A
Hum Gene Ther; 1995 Jan; 6(1):107-19. PubMed ID: 7703282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
